{"id":"https://openalex.org/W2187828783","doi":"https://doi.org/10.1158/1538-7445.am2015-2603","title":"Abstract 2603: Combination activity of the MEK inhibitor Pimasertib and the hypoxia-activated prodrug TH-302 in pancreatic and biliary tract tumor xenograft models","display_name":"Abstract 2603: Combination activity of the MEK inhibitor Pimasertib and the hypoxia-activated prodrug TH-302 in pancreatic and biliary tract tumor xenograft models","alternate_titles":[],"publication_year":2015,"publication_date":"2015-08-01","ids":{"openalex":"https://openalex.org/W2187828783","doi":"https://doi.org/10.1158/1538-7445.am2015-2603","mag":"2187828783"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2015-2603","doi":"https://doi.org/10.1158/1538-7445.am2015-2603","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-2603","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2187828783"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100962170","display_name":"Jianguo Ma","orcid":"https://orcid.org/0009-0007-5184-7550","observed_orcids":["https://orcid.org/0009-0007-5184-7550"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianguo Ma","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041362936","display_name":"Sakeena Syed","orcid":"https://orcid.org/0000-0003-3887-7521","observed_orcids":["https://orcid.org/0000-0003-3887-7521"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sakeena Syed","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069779817","display_name":"Lindsey Crowley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lindsey Crowley","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045381285","display_name":"Jamie V. Shaw","orcid":"https://orcid.org/0000-0001-5131-7639","observed_orcids":["https://orcid.org/0000-0001-5131-7639"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie Shaw","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079155002","display_name":"Janet Ogden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janet Ogden","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008405453","display_name":"Brian Elenbaas","orcid":"https://orcid.org/0000-0002-7892-6028","observed_orcids":["https://orcid.org/0000-0002-7892-6028"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Elenbaas","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068757483","display_name":"Samantha M. Goodstal","orcid":"https://orcid.org/0000-0001-6083-8479","observed_orcids":["https://orcid.org/0000-0001-6083-8479"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samantha Goodstal","raw_affiliation_strings":["EMD Serono, Inc., Billerica, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc., Billerica, MA","institution_ids":["https://openalex.org/I4210111614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210111614"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"75","issue":"15_Supplement","first_page":"2603","last_page":"2603"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11364","display_name":"Cholangiocarcinoma and Gallbladder Cancer Studies","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pimasertib","display_name":"pimasertib","score":0.847000002861023},{"id":"https://openalex.org/keywords/th-302","display_name":"TH-302","score":0.9100000262260437},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hypoxia-activated-prodrug","display_name":"hypoxia-activated prodrug","score":0.9729999899864197},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/biliary-tract-cancer","display_name":"biliary tract cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cholangiocarcinoma","display_name":"cholangiocarcinoma","score":1.0},{"id":"https://openalex.org/keywords/gallbladder-cancer","display_name":"gallbladder cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8429999947547913},{"id":"https://openalex.org/keywords/mia-paca-2-cells","display_name":"MIA PaCa-2 cells","score":0.8009999990463257},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7730000019073486},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.8569999933242798},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.45100000500679016},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8094334006309509},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.7063425779342651},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.658039927482605},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6515815258026123},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.6197618842124939},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4699711203575134},{"id":"https://openalex.org/C2775982439","wikidata":"https://www.wikidata.org/wiki/Q3562150","display_name":"Biliary tract","level":2,"score":0.45374566316604614},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42900437116622925},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.4168103337287903},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3804932236671448},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29553496837615967}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2015-2603","doi":"https://doi.org/10.1158/1538-7445.am2015-2603","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2015-2603","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2321195108","https://openalex.org/W2270608458","https://openalex.org/W2157943512","https://openalex.org/W1981966529","https://openalex.org/W1479725025","https://openalex.org/W2071777106","https://openalex.org/W2803544044","https://openalex.org/W2966750515","https://openalex.org/W2525328248","https://openalex.org/W2493024902"],"abstract_inverted_index":{"Abstract":[0],"The":[1,107,149,171,201],"efficacy":[2,36,162,174],"and":[3,10,20,61,67,72,88,118,136,139,165,211,234,341,348],"tolerability":[4],"of":[5,45,50,58,100,126,143,214,336,357,362],"the":[6,11,32,59,95,123,137,154,194,249,311,337,342,358,363],"MEK":[7,131,338],"inhibitor":[8,339],"Pimasertib":[9,66,71,177,232,250,288,340],"hypoxia-activated":[12,343],"prodrug":[13,344],"TH-302":[14,68,73,251,290,345],"combination":[15,35,103,108,161,173,189,202,252,293,316],"were":[16,29,229,269,284],"explored":[17,205],"in":[18,78,82,104,112,147,153,191,206,272,346],"pancreatic":[19,83,105,158,209,275,347],"biliary":[21,113,215,349],"tract":[22,114,216,350],"preclinical":[23],"tumor":[24,63,128,351],"xenograft":[25,159,218,352],"models.":[26,220,353],"These":[27],"studies":[28],"based":[30,121],"on":[31,122],"hypotheses":[33],"that":[34,152,305],"may":[37],"occur":[38],"by":[39,52,55,65],"several":[40],"possible":[41],"mechanisms":[42],"including":[43],"inhibition":[44],"DNA":[46],"repair":[47],"or":[48,54,276,289],"increase":[49],"hypoxia":[51],"Pimasertib,":[53],"differential":[56],"targeting":[57],"oxic":[60],"hypoxic":[62,134],"compartments":[64],"respectively.":[69],"Since":[70],"had":[74],"each":[75],"been":[76],"tested":[77,111],"separate":[79],"clinical":[80,98,263],"trials":[81],"cancer":[84,115],"with":[85,242,248],"gemcitabine":[86],"(NCT01016483":[87],"NCT01144455":[89],"respectively),":[90],"these":[91,127,144],"data":[92],"could":[93,306],"provide":[94],"rationale":[96],"for":[97,366],"testing":[99],"this":[101,315],"novel":[102],"cancer.":[106],"was":[109,163,178,203],"also":[110],"models":[116,210,225,228,236,280,283],"(cholangiocarcinoma":[117],"gall":[119,278],"bladder)":[120],"reported":[124],"sensitivity":[125],"types":[129],"to":[130,167,184,231,245,261,287,296,302,314],"inhibitors,":[132],"their":[133],"nature,":[135],"prevalence":[138],"high":[140],"unmet":[141],"need":[142],"indications,":[145],"particularly":[146],"Asia.":[148],"results":[150],"showed":[151],"MIA":[155],"PaCa-2":[156],"human":[157],"model,":[160],"observed":[164,271],"found":[166],"be":[168],"schedule":[169],"dependent.":[170],"greatest":[172],"occurred":[175],"when":[176,193],"administered":[179],"first,":[180],"2":[181,207,273],"hours":[182],"prior":[183],"TH-302,":[185],"suggesting":[186],"a":[187,212,240,246,262],"unique":[188],"mechanism":[190],"cells":[192],"MAPK":[195],"signaling":[196],"pathway":[197],"is":[198,259],"suppressed":[199],"first.":[200],"subsequently":[204],"additional":[208,274],"panel":[213],"patient-derived":[217],"(PDX)":[219],"In":[221],"10":[222],"cholangiocarcinoma":[223],"PDX":[224],"tested,":[226],"3":[227],"responders":[230],"monotherapy":[233,244],"4":[235],"converted":[237],"from":[238],"being":[239],"non-responder":[241],"either":[243],"responder":[247],"using":[253],"the%TV":[254],"(tumor":[255],"volume)":[256],"criteria,":[257],"which":[258,308],"related":[260],"PR":[264],"RECIST":[265],"response.":[266],"Combination":[267,334],"effects":[268,294],"not":[270],"6":[277],"bladder":[279],"tested.":[281],"Some":[282],"highly":[285],"sensitive":[286,313],"monotherapy,":[291],"making":[292],"difficult":[295],"observe.":[297],"Biomarker":[298],"analyses":[299],"are":[300,310],"ongoing":[301],"identify":[303],"markers":[304],"predict":[307],"tumors":[309],"most":[312],"therapy.":[317],"Citation":[318],"Format:":[319],"Jianguo":[320],"Ma,":[321],"Sakeena":[322],"Syed,":[323],"Lindsey":[324],"Crowley,":[325],"Jamie":[326],"Shaw,":[327],"Janet":[328],"Ogden,":[329],"Brian":[330],"Elenbaas,":[331],"Samantha":[332],"Goodstal.":[333],"activity":[335],"[abstract].":[354],"In:":[355],"Proceedings":[356],"106th":[359],"Annual":[360],"Meeting":[361],"American":[364],"Association":[365],"Cancer":[367,377],"Research;":[368],"2015":[369],"Apr":[370],"18-22;":[371],"Philadelphia,":[372],"PA.":[373],"Philadelphia":[374],"(PA):":[375],"AACR;":[376],"Res":[378],"2015;75(15":[379],"Suppl):Abstract":[380],"nr":[381],"2603.":[382],"doi:10.1158/1538-7445.AM2015-2603":[383]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2187828783","counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}
